Answers are grounded in this paper and cite their sources.
Both frailty and sarcopenia are more common in PD patients than in the general community and are associated with a more adverse course of the disease. Future studies should look into underlying risk factors for the occurrence of sarcopenia and frailty in PD patients and into adequate management to prevent and mitigate them.
No takes yet. Share an insight, caveat, or question.
Peball et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: